DarioHealth Corp. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
DarioHealth Corp. (DRIO) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $19.15 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-19
- DarioHealth Corp. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $19.15M, a 1.42% increase from fiscal 2024.
- DarioHealth Corp. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $18.89M, a 225.73% increase from fiscal 2023.
- DarioHealth Corp. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $5.80M, a 47.21% decline from fiscal 2022.
- DarioHealth Corp. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $10.98M, a 35.71% decline from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | $19.15M 10-K · filed 2026-03-19 |
| 2024-12-31 | $18.89M 10-K · filed 2026-03-19 |
| 2023-12-31 | $5.80M 10-K · filed 2024-03-28 |
| 2022-12-31 | $10.98M 10-K · filed 2023-03-09 |
| 2021-12-31 | $17.09M 10-K · filed 2022-03-22 |
| 2020-12-31 | $6.67M 10-K · filed 2021-03-09 |
| 2019-12-31 | $6.68M 10-K · filed 2020-03-17 |
| 2018-12-31 | $329.00K 10-K · filed 2019-03-25 |
| 2017-12-31 | $1.02K 10-K · filed 2018-03-19 |
| 2016-12-31 | $2.78M 10-K · filed 2017-03-22 |
| 2015-12-31 | $1.59M 10-K · filed 2016-02-08 |
| 2014-12-31 | $1.98M 10-K · filed 2015-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |